Similarly, CXCL8, a chemokine implicated in tumor-related inflammation and immune modulation, could provide a unique window into the tumor microenvironment’s role in metastasis [23], distinguishing it from biomarkers like HER2, which are more associated with cell signaling and proliferation [24]. This evidence concerns the gene ERBB2 and neoplasm.